STOCKWATCH
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Quarterly ResultMay 11, 2026, 07:16 AM

United Parks & Resorts Q1 Net Loss $34.1M; Revenue $278.3M

AI Summary

United Parks & Resorts Inc. reported a net loss of $34.1 million on $278.3 million in revenue for Q1 2026, missing expectations due to unfavorable weather and a decline in international attendance. Despite the revenue and attendance decrease, in-park per capita spending reached a record $40.62, and the company repurchased approximately 2.6 million shares for $92.7 million during the quarter, with further repurchases post-quarter. Management expressed confidence in upcoming new attractions and strong forward indicators for 2026.

Key Highlights

  • Attendance decreased by 171,000 guests to 3.2 million, down 5.0% from Q1 2025.
  • Total revenue was $278.3 million, an $8.7 million decrease (3.0%) from Q1 2025.
  • Net loss was $34.1 million, a $17.9 million increase in loss (111.2%) from Q1 2025.
  • Adjusted EBITDA was $58.0 million, a $9.5 million decrease (14.1%) from Q1 2025.
  • Total revenue per capita increased 2.1% to $86.43.
  • In-park per capita spending increased 5.3% to a record $40.62.
  • Company repurchased 2.6 million shares for $92.7 million in Q1 2026.
  • An additional 1.8 million shares were repurchased for $64.8 million through May 8, 2026.
PRKS
Biotechnology: Electromedical & Electrotherapeutic Apparatus
United Parks & Resorts Inc.

Price Impact